Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Avian Influenza
Tuttle joins HepaLife to expedite development of bird flu vaccine
February 14th, 2007
HepaLife Technologies, Inc. (HPLF) announced the addition of Dr. Robert C. Tuttle to the company's Scientific Advisory Board. With more than 25 years of experience, Tuttle is widely regarded as an innovative, pioneering cell and tissue culture biologist, with extensive biopharmaceutical experience in cGMP pilot to commercial scale GMP culture, including three FDA approved human therapeutics and seven in clinical trials. "In addition to his industry-wide experience, Dr. Tuttle's unique blend of scientific know-how and commercial scale-up expertise in cell-cultures and vaccines are very helpful for us," states Frank Menzler, president and CEO of...
Source: Medical Patent Law Weekly (2007-02-14)
|
